Title: Dynamic Variations in Peripheral Blood Indices and Their Association with Efficacy
and Adverse Reactions of PD-1 Inhibitor Combined Chemotherapy in Patients with Advanced
Gastric Cancer
Version: 4 Date: 30 Jan 2025
Reviewer:  Mohamed H. Zidan
Reviewer's report:
Dear Authors,
The study titled "Dynamic Variations in Peripheral Blood Indices and Their Association with
Efficacy and Adverse Reactions of PD-1 Inhibitor Combined Chemotherapy in Patients with
Advanced Gastric Cancer" provides an insightful retrospective study on peripheral blood
biomarkers in predicting response and prognosis in gastric cancer patients receiving PD-1
inhibitor-based immunotherapy. The study is methodologically sound, employing statistical
modeling to evaluate associations between inflammatory markers, tumor markers, and clinical
outcomes.
I have no comments
Title: Dynamic Variations in Peripheral Blood Indices and Their Association with Efficacy
and Adverse Reactions of PD-1 Inhibitor Combined Chemotherapy in Patients with Advanced
Gastric Cancer
Version: 4 Date: 30 Jan 2025
Reviewer:  Mohamed H. Zidan
Reviewer's report:
Dear Authors,
The study titled "Dynamic Variations in Peripheral Blood Indices and Their Association with
Efficacy and Adverse Reactions of PD-1 Inhibitor Combined Chemotherapy in Patients with
Advanced Gastric Cancer" provides an insightful retrospective study on peripheral blood
biomarkers in predicting response and prognosis in gastric cancer patients receiving PD-1
inhibitor-based immunotherapy. The study is methodologically sound, employing statistical
modeling to evaluate associations between inflammatory markers, tumor markers, and clinical
outcomes.
I have no comments
Please review this paper.
user
Title: Dynamic Variations in Peripheral Blood Indices and Their Association with Efficacy
and Adverse Reactions of PD-1 Inhibitor Combined Chemotherapy in Patients with Advanced
Gastric Cancer
Version: 4 Date: 30 Jan 2025
Reviewer:  Mohamed H. Zidan
Reviewer's report:
Dear Authors,
The study titled "Dynamic Variations in Peripheral Blood Indices and Their Association with
Efficacy and Adverse Reactions of PD-1 Inhibitor Combined Chemotherapy in Patients with
Advanced Gastric Cancer" provides an insightful retrospective study on peripheral blood
biomarkers in predicting response and prognosis in gastric cancer patients receiving PD-1
inhibitor-based immunotherapy. The study is methodologically sound, employing statistical
modeling to evaluate associations between inflammatory markers, tumor markers, and clinical
outcomes.
I have no comments
assistant